Latest Insider Transactions at Allovir, Inc. (ALVR)
This section provides a real-time view of insider transactions for Allovir, Inc. (ALVR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Allovir, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Allovir, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 19
2023
|
Diana Brainard Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
34,435
-5.41%
|
$172,175
$5.08 P/Share
|
|
Jan 19
2023
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,557
-2.05%
|
$7,785
$5.08 P/Share
|
|
Jan 19
2023
|
Edward Miller General Counsel |
SELL
Open market or private sale
|
Direct |
2,032
-1.35%
|
$10,160
$5.08 P/Share
|
|
Jan 19
2023
|
Vikas Sinha |
SELL
Open market or private sale
|
Direct |
5,111
-0.49%
|
$25,555
$5.08 P/Share
|
|
Dec 02
2022
|
Edward Miller General Counsel |
BUY
Bona fide gift
|
Indirect |
98,346
+25.4%
|
-
|
|
Dec 02
2022
|
Edward Miller General Counsel |
SELL
Bona fide gift
|
Direct |
98,346
-39.44%
|
-
|
|
Nov 18
2022
|
Diana Brainard Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,515
-0.71%
|
$31,605
$7.27 P/Share
|
|
Nov 16
2022
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
16,074
-4.6%
|
$112,518
$7.5 P/Share
|
|
Nov 14
2022
|
Edward Miller General Counsel |
SELL
Open market or private sale
|
Indirect |
2,358
-1.22%
|
$18,864
$8.91 P/Share
|
|
Nov 11
2022
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
36,592
-9.47%
|
$292,736
$8.2 P/Share
|
|
Nov 11
2022
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
18,011
-19.18%
|
$144,088
$8.18 P/Share
|
|
Nov 10
2022
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,989
-6.0%
|
$47,912
$8.0 P/Share
|
|
Nov 10
2022
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
13,109
-3.28%
|
$104,872
$8.0 P/Share
|
|
Nov 08
2022
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
299
-0.07%
|
$2,392
$8.0 P/Share
|
|
Oct 24
2022
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,000
-1.96%
|
$16,000
$8.13 P/Share
|
|
Oct 21
2022
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
11,334
-10.01%
|
$90,672
$8.45 P/Share
|
|
Oct 20
2022
|
Ercem Atillasoy Officer |
SELL
Open market or private sale
|
Direct |
1,527
-1.15%
|
$12,216
$8.48 P/Share
|
|
Oct 19
2022
|
Ercem Atillasoy Officer |
SELL
Open market or private sale
|
Direct |
568
-0.43%
|
$5,112
$9.36 P/Share
|
|
Oct 19
2022
|
Edward Miller General Counsel |
SELL
Open market or private sale
|
Direct |
553
-0.22%
|
$4,977
$9.36 P/Share
|
|
Oct 19
2022
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
345
-0.3%
|
$3,105
$9.36 P/Share
|
|
Oct 19
2022
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,070
-0.27%
|
$9,630
$9.36 P/Share
|
|
Oct 19
2022
|
Vikas Sinha |
SELL
Open market or private sale
|
Direct |
1,449
-0.14%
|
$13,041
$9.36 P/Share
|
|
Oct 19
2022
|
David Hallal |
SELL
Open market or private sale
|
Indirect |
600,000
-81.28%
|
$4,800,000
$8.45 P/Share
|
|
Sep 29
2022
|
David Hallal |
SELL
Open market or private sale
|
Indirect |
400,000
-35.68%
|
$2,800,000
$7.35 P/Share
|
|
Sep 02
2022
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
493
-0.12%
|
$3,451
$7.89 P/Share
|
|
Aug 18
2022
|
Diana Brainard Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,564
-0.71%
|
$31,948
$7.76 P/Share
|
|
Aug 16
2022
|
Ann M. Leen Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+25.86%
|
-
|
|
Aug 16
2022
|
Vikas Sinha |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+8.79%
|
-
|
|
Aug 16
2022
|
Edward Miller General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+5.66%
|
-
|
|
Aug 16
2022
|
Diana Brainard Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+13.48%
|
-
|
|
Aug 16
2022
|
Jeroen B Van Beek Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+3.6%
|
-
|
|
Aug 16
2022
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
15,590
-3.88%
|
$124,720
$8.3 P/Share
|
|
Aug 16
2022
|
Brett R Hagen Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+14.97%
|
-
|
|
Jul 28
2022
|
Vikas Sinha |
BUY
Grant, award, or other acquisition
|
Indirect |
3,253,796
+16.33%
|
$13,015,184
$4.61 P/Share
|
|
Jul 28
2022
|
David Hallal |
BUY
Grant, award, or other acquisition
|
Indirect |
3,253,796
+16.33%
|
$13,015,184
$4.61 P/Share
|
|
Jul 28
2022
|
Morana Jovan Embiricos |
BUY
Grant, award, or other acquisition
|
Indirect |
8,152,247
+32.23%
|
$32,608,988
$4.61 P/Share
|
|
Jul 28
2022
|
Elevate Bio, LLC Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,253,796
+16.33%
|
$13,015,184
$4.61 P/Share
|
|
Jul 28
2022
|
Ansbert Gadicke Director |
BUY
Grant, award, or other acquisition
|
Indirect |
3,253,796
+16.33%
|
$13,015,184
$4.61 P/Share
|
|
Jul 21
2022
|
Ercem Atillasoy Officer |
SELL
Open market or private sale
|
Direct |
1,533
-1.14%
|
$7,665
$5.38 P/Share
|
|
Jul 21
2022
|
David Hallal |
SELL
Open market or private sale
|
Direct |
4,227
-0.2%
|
$21,135
$5.33 P/Share
|
|
Jul 20
2022
|
Vikas Sinha |
SELL
Open market or private sale
|
Direct |
1,432
-0.15%
|
$7,160
$5.21 P/Share
|
|
Jul 20
2022
|
Ercem Atillasoy Officer |
SELL
Open market or private sale
|
Direct |
563
-0.42%
|
$2,815
$5.21 P/Share
|
|
Jul 20
2022
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,058
-0.26%
|
$5,290
$5.21 P/Share
|
|
Jul 01
2022
|
Ann M. Leen Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+17.66%
|
-
|
|
Jul 01
2022
|
Brett R Hagen Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,500
+10.09%
|
-
|
|
Jul 01
2022
|
Edward Miller General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+5.62%
|
-
|
|
Jul 01
2022
|
Vikas Sinha |
BUY
Grant, award, or other acquisition
|
Direct |
29,400
+3.03%
|
-
|
|
Jul 01
2022
|
Ercem Atillasoy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+9.36%
|
-
|
|
Jul 01
2022
|
Diana Brainard Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,125
+8.15%
|
-
|
|
Jul 01
2022
|
Jeroen B Van Beek Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+3.36%
|
-
|